Recent Annual Filings for BIO.B

Fiscal Year Assets Revenues Costs & Expenses Comprehensive Income Cash Flow - Operating Cash Flow - Financing Total Net Cash Flow
2023 $12,299,070,000 $2,671,300,000 $3,521,404,000 $-506,540,000 $374,943,000 $-425,647,000 $-30,496,000
2022 $13,501,666,000 $2,802,200,000 $7,506,473,000 $-3,918,804,000 $194,447,000 $973,576,000 $-39,570,000
2021 $17,775,795,000 $2,922,500,000 $-2,515,649,000 $3,787,893,000 $656,521,000 $-55,429,000 $-195,982,000
2020 $12,972,618,000 $2,545,600,000 $-2,362,038,000 $4,176,071,000 $575,328,000 $-523,041,000 $4,464,000
2019 $8,008,859,000 $2,311,700,000 $50,619,000 $1,718,285,000 $457,897,000 $-22,758,000 $228,487,000
2018 $5,611,068,000 $2,289,400,000 $1,776,741,000 $259,119,000 $285,494,000 $-48,680,000 $49,181,000
2017 $4,273,012,000 $2,160,153,000 $2,062,348,000 $443,277,000 $103,885,000 $341,000 $-72,440,000
2015 $3,711,542,000 $2,019,441,000 $1,873,594,000 $276,286,000 $186,210,000 $8,581,000 $44,298,000